Jennifer Melinda Melcomian
Family · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jennifer Melinda Melcomian’s office at (669) 317-9835 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$15,752
Medicare paid this office $15,752 for 146 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 59 | $6,158 | $92 |
| New patient visit (45+ min) | 45 | $4,611 | $102 |
| Short return visit (20+ min) | 25 | $1,526 | $59 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 30 | $1,257 | $41 |
| New patient visit (30+ min) | 14 | $911 | $65 |
See all 8 services
| Return visit (30+ min) | 59 | $6,158 | $92 |
| New patient visit (45+ min) | 45 | $4,611 | $102 |
| Short return visit (20+ min) | 25 | $1,526 | $59 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 30 | $1,257 | $41 |
| New patient visit (30+ min) | 14 | $911 | $65 |
| Detection test by immunoassay with direct visual observation for influenza virus | 12 | $389 | $16 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 13 | $211 | $16 |
| Automated urinalysis test | 13 | $29 | $2 |
Who their Medicare patients are
146 Original Medicare patients in 2024. Average age 73 · Women 69% · Also on Medicaid 8% · Health risk score 0.83. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 66% · Diabetes 26% · Coronary heart disease 19% · Depression 16% · Chronic kidney disease 15% · Cancer 14% · Atrial fibrillation 12% · Heart failure 8%.
The office billed $77,202, Medicare allowed $23,330 and paid $15,752; for 261 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 146 | 261 | 73 | 0.83 | $77,202 | $15,752 |
| 2023 | 103 | 193 | 74 | 0.85 | $41,088 | $6,096 |
| 2022 | 578 | 1,137 | 75 | 0.89 | $255,095 | $56,542 |
| 2021 | 58 | 119 | 72 | 0.82 | $13,580 | $5,578 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Short return visit (20+ min) | 65 | $2,952 | $45 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 19 | $1,184 | $62 |
| New patient visit (30+ min) | 24 | $898 | $37 |
2022: 11 services
| Return visit (30+ min) | 174 | $15,589 | $89 |
| Short return visit (20+ min) | 200 | $14,202 | $68 |
| New patient visit (45+ min) | 106 | $12,312 | $116 |
| New patient visit (30+ min) | 81 | $6,695 | $83 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | 125 | $3,897 | $30 |
| New patient visit (15+ min) | 14 | $666 | $48 |
| Short return visit | 14 | $593 | $42 |
| X-ray of chest, 2 views | 23 | $463 | $20 |
| X-ray of foot, minimum of 3 views | 12 | $292 | $24 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 14 | $228 | $16 |
| Automated urinalysis test | 91 | $208 | $2 |
2021: 4 services
| New patient visit (45+ min) | 20 | $2,069 | $103 |
| Return visit (30+ min) | 12 | $1,023 | $85 |
| New patient visit (30+ min) | 14 | $959 | $68 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 14 | $495 | $35 |
Medicaid work
$4,013 in 2021
Medicaid paid $4,013 for 201 billed services this clinician did in 2021, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (45+ min) | 17 | $2,194 |
| Return visit (30+ min) | 21 | $1,778 |
| SARSCOV CORONAVIRUS AG IA | 53 | $31 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 54 | $5 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 40 | $5 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 16 | $0 |
| 2021 | 201 | 6 | 27 | $4,013 |
Drugs they prescribed that Part D paid
$9,439
Pharmacies billed $9,439 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 195) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
173 generic and fewer than 11 brand-name prescriptions · $9,439 in drug cost · 75 antibiotic prescriptions to 72 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 15 | $439 | $29 |
| Nitrofurantoin Mono-Macro | 12 | $141 | $12 |
| Cephalexin | 17 | $84 | $5 |
| Azithromycin | 14 | $37 | $3 |
Year by year
| 2024 | 195 | 135 | 0% (0) | None | $9,439 |
| 2023 | 143 | 105 | 0% (0) | None | $6,816 |
| 2022 | 379 | 311 | 0% (0) | None | $4,166 |
| 2021 | 87 | 61 | None | None | $1,034 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Cephalexin | 14 | $131 | $9 |
| Azithromycin | 13 | $53 | $4 |
2022: 9 drugs
| Azithromycin | 93 | $428 | $5 |
| Amoxicillin-Clavulanate Potass | 34 | $396 | $12 |
| Albuterol Sulfate Hfa | 11 | $370 | $34 |
| Cephalexin | 44 | $328 | $7 |
| Doxycycline Hyclate | 23 | $296 | $13 |
| Nitrofurantoin Mono-Macro | 22 | $288 | $13 |
| Sulfamethoxazole-Trimethoprim | 19 | $88 | $5 |
| Triamcinolone Acetonide | 12 | $48 | $4 |
| Prednisone | 14 | $37 | $3 |
2021: 2 drugs
| Cephalexin | 15 | $96 | $6 |
| Ciprofloxacin | 15 | $83 | $6 |
Money from drug and device companies
$154 in 2025
A payment is not proof that care is biased.
| Teva Pharmaceuticals USA | Uzedy | $125 | 1 payment
|
| Alkermes | Aristada | $29 | 1 payment
|
See all 2 published payments
| Teva Pharmaceuticals USA | Meals · 2025-12-18 | Uzedy | $125 |
| Alkermes | Meals · 2025-12-17 | Aristada | $29 |
Professional record
- NPI
- 1487119491
- Licence
- UT 5349909-4405
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 6469 Almaden Expy Ste 80-703, San Jose, CA, 95120
- NPI first listed
- 2019-02-04
- NPI last updated
- 2025-03-13
- NPI record certified
- 2025-03-13
This is when the NPI record was last certified, not a medical board exam.